vs
Side-by-side financial comparison of FRESH DEL MONTE PRODUCE INC (FDP) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.0B, roughly 1.4× FRESH DEL MONTE PRODUCE INC). FRESH DEL MONTE PRODUCE INC runs the higher net margin — 3.2% vs 1.4%, a 1.7% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs 0.6%). SELECT MEDICAL HOLDINGS CORP produced more free cash flow last quarter ($5.2M vs $-17.2M). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs -4.1%).
Fresh Del Monte Produce Incorporated is one of the world’s leading vertically integrated producers, distributors, and marketers of prepared, fresh and fresh-cut fruits and vegetables. Incorporated in George Town, Cayman Islands, its US executive office is located at 241 Sevilla Avenue, Coral Gables, Florida.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
FDP vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.4B |
| Net Profit | $32.3M | $20.2M |
| Gross Margin | 10.4% | — |
| Operating Margin | 4.5% | 4.6% |
| Net Margin | 3.2% | 1.4% |
| Revenue YoY | 0.6% | 6.4% |
| Net Profit YoY | 59.1% | 225.7% |
| EPS (diluted) | $0.67 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.4B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $1.0B | $1.3B | ||
| Q2 24 | $1.1B | $1.3B | ||
| Q1 24 | $1.1B | $1.3B |
| Q4 25 | $32.3M | $20.2M | ||
| Q3 25 | $-29.1M | $28.8M | ||
| Q2 25 | $56.8M | $40.6M | ||
| Q1 25 | $31.1M | $56.7M | ||
| Q4 24 | $20.3M | $-16.1M | ||
| Q3 24 | $42.1M | $55.6M | ||
| Q2 24 | $53.6M | $77.6M | ||
| Q1 24 | $26.1M | $96.9M |
| Q4 25 | 10.4% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 6.8% | — | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 7.4% | — |
| Q4 25 | 4.5% | 4.6% | ||
| Q3 25 | -2.1% | 5.4% | ||
| Q2 25 | 5.8% | 6.5% | ||
| Q1 25 | 4.1% | 8.3% | ||
| Q4 24 | 3.0% | 1.6% | ||
| Q3 24 | 5.3% | 4.3% | ||
| Q2 24 | 6.0% | 5.8% | ||
| Q1 24 | 4.0% | 9.0% |
| Q4 25 | 3.2% | 1.4% | ||
| Q3 25 | -2.8% | 2.1% | ||
| Q2 25 | 4.8% | 3.0% | ||
| Q1 25 | 2.8% | 4.2% | ||
| Q4 24 | 2.0% | -1.2% | ||
| Q3 24 | 4.1% | 4.4% | ||
| Q2 24 | 4.7% | 6.1% | ||
| Q1 24 | 2.4% | 7.3% |
| Q4 25 | $0.67 | $0.17 | ||
| Q3 25 | $-0.61 | $0.23 | ||
| Q2 25 | $1.18 | $0.32 | ||
| Q1 25 | $0.64 | $0.44 | ||
| Q4 24 | $0.41 | $-0.12 | ||
| Q3 24 | $0.88 | $0.43 | ||
| Q2 24 | $1.12 | $0.60 | ||
| Q1 24 | $0.55 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $35.7M | $26.5M |
| Total DebtLower is stronger | $176.2M | $1.8B |
| Stockholders' EquityBook value | $2.0B | $1.7B |
| Total Assets | $3.1B | $5.9B |
| Debt / EquityLower = less leverage | 0.09× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.7M | $26.5M | ||
| Q3 25 | $97.2M | $60.1M | ||
| Q2 25 | $85.5M | $52.3M | ||
| Q1 25 | $34.4M | $53.2M | ||
| Q4 24 | $32.6M | $59.7M | ||
| Q3 24 | $50.8M | $191.5M | ||
| Q2 24 | $37.8M | $111.2M | ||
| Q1 24 | $42.2M | $92.6M |
| Q4 25 | $176.2M | $1.8B | ||
| Q3 25 | $176.7M | $1.7B | ||
| Q2 25 | $205.2M | $1.8B | ||
| Q1 25 | $237.4M | $1.8B | ||
| Q4 24 | $248.9M | $1.7B | ||
| Q3 24 | $274.8M | $3.1B | ||
| Q2 24 | $290.4M | $3.6B | ||
| Q1 24 | $405.8M | $3.8B |
| Q4 25 | $2.0B | $1.7B | ||
| Q3 25 | $2.0B | $1.7B | ||
| Q2 25 | $2.1B | $1.7B | ||
| Q1 25 | $2.0B | $1.7B | ||
| Q4 24 | $2.0B | $1.7B | ||
| Q3 24 | $2.0B | $1.9B | ||
| Q2 24 | $2.0B | $1.4B | ||
| Q1 24 | $1.9B | $1.4B |
| Q4 25 | $3.1B | $5.9B | ||
| Q3 25 | $3.1B | $5.7B | ||
| Q2 25 | $3.2B | $5.7B | ||
| Q1 25 | $3.2B | $5.7B | ||
| Q4 24 | $3.1B | $5.6B | ||
| Q3 24 | $3.2B | $8.0B | ||
| Q2 24 | $3.1B | $7.9B | ||
| Q1 24 | $3.2B | $7.9B |
| Q4 25 | 0.09× | 1.06× | ||
| Q3 25 | 0.09× | 1.03× | ||
| Q2 25 | 0.10× | 1.10× | ||
| Q1 25 | 0.12× | 1.03× | ||
| Q4 24 | 0.13× | 1.01× | ||
| Q3 24 | 0.14× | 1.62× | ||
| Q2 24 | 0.15× | 2.54× | ||
| Q1 24 | 0.21× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.9M | $64.3M |
| Free Cash FlowOCF − Capex | $-17.2M | $5.2M |
| FCF MarginFCF / Revenue | -1.7% | 0.4% |
| Capex IntensityCapex / Revenue | 2.8% | 4.2% |
| Cash ConversionOCF / Net Profit | 0.34× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $181.3M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.9M | $64.3M | ||
| Q3 25 | $75.0M | $175.3M | ||
| Q2 25 | $113.1M | $110.3M | ||
| Q1 25 | $46.1M | $-3.5M | ||
| Q4 24 | $-4.7M | $125.4M | ||
| Q3 24 | $43.5M | $181.0M | ||
| Q2 24 | $125.0M | $278.2M | ||
| Q1 24 | $18.7M | $-66.7M |
| Q4 25 | $-17.2M | $5.2M | ||
| Q3 25 | $60.9M | $122.2M | ||
| Q2 25 | $101.5M | $45.6M | ||
| Q1 25 | $36.1M | $-55.8M | ||
| Q4 24 | $-22.3M | $62.0M | ||
| Q3 24 | $30.1M | $130.3M | ||
| Q2 24 | $117.0M | $222.6M | ||
| Q1 24 | $6.0M | $-119.2M |
| Q4 25 | -1.7% | 0.4% | ||
| Q3 25 | 6.0% | 9.0% | ||
| Q2 25 | 8.6% | 3.4% | ||
| Q1 25 | 3.3% | -4.1% | ||
| Q4 24 | -2.2% | 4.7% | ||
| Q3 24 | 3.0% | 10.2% | ||
| Q2 24 | 10.3% | 17.4% | ||
| Q1 24 | 0.5% | -9.0% |
| Q4 25 | 2.8% | 4.2% | ||
| Q3 25 | 1.4% | 3.9% | ||
| Q2 25 | 1.0% | 4.8% | ||
| Q1 25 | 0.9% | 3.9% | ||
| Q4 24 | 1.7% | 4.8% | ||
| Q3 24 | 1.3% | 4.0% | ||
| Q2 24 | 0.7% | 4.3% | ||
| Q1 24 | 1.1% | 4.0% |
| Q4 25 | 0.34× | 3.19× | ||
| Q3 25 | — | 6.09× | ||
| Q2 25 | 1.99× | 2.72× | ||
| Q1 25 | 1.48× | -0.06× | ||
| Q4 24 | -0.23× | — | ||
| Q3 24 | 1.03× | 3.25× | ||
| Q2 24 | 2.33× | 3.59× | ||
| Q1 24 | 0.72× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDP
| Other | $482.7M | 47% |
| Gold Pineapples | $184.9M | 18% |
| Fresh Cut Fruit | $126.4M | 12% |
| Fresh Cut Vegetables | $69.3M | 7% |
| Avocados | $66.9M | 7% |
| Other Fruit Productsand Services | $26.1M | 3% |
| Non Tropical Fruit | $23.0M | 2% |
| Melons | $20.6M | 2% |
| Vegetables | $19.6M | 2% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
